» Articles » PMID: 25506892

Vitamin D Receptor Signaling and Pancreatic Cancer Cell EMT

Overview
Journal Curr Pharm Des
Date 2014 Dec 16
PMID 25506892
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic ductal adenocarcinoma (PDAC) still remains one of the most fatal human malignant tumors. Long-term survival rate is still extremely pathetic even for patients who receive surgery. Epithelial-to-mesenchymal transition (EMT), which is a physiologic process of morphological as well as genetic changes in carcinoma cells, plays a vital role in aggressiveness of PDAC. Meanwhile EMT is also the reason why pancreatic cancer cells achieve such huge metastatic potentials. Many tumor microenvironmental factors such as cytokines, growth factors, as well as chemotherapeutic agents may induce EMT. Our study provides evidence regarding effects of EMT on pancreatic cancer progression, focusing on the correlation between EMT and other pathways which are crucial to tumor progression, especially vitamin D receptor signaling pathway. Research on signal pathways resulting in EMT inactivation during these disease processes may offer innovative ideas on plasticity of cellular phenotypes as well as possible therapeutic interventions.

Citing Articles

The therapeutic potential of vitamins A, C, and D in pancreatic cancer.

Piotrowsky A, Burkard M, Schmieder H, Venturelli S, Renner O, Marongiu L Heliyon. 2025; 11(1):e41598.

PMID: 39850424 PMC: 11754517. DOI: 10.1016/j.heliyon.2024.e41598.


The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma.

Gao W, Wang T, Yi W, Tong W Transl Cancer Res. 2022; 9(8):4476-4487.

PMID: 35117813 PMC: 8798510. DOI: 10.21037/tcr.2020.02.78.


The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.

Herting C, Karpovsky I, Lesinski G Cancer Metastasis Rev. 2021; 40(3):675-689.

PMID: 34591240 DOI: 10.1007/s10555-021-09988-w.


Possible role of vitamin D3 on the adipocyte/fibroblast trans-differentiation mediated by pancreas cancer.

Chirumbolo S Curr Health Sci J. 2018; 41(1):5-10.

PMID: 30151244 PMC: 6057533. DOI: 10.12865/CHSJ.41.01.01.


1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.

Yang L, Fan Y, Zhang X, Huang W, Ma J Mol Med Rep. 2017; 16(4):3817-3824.

PMID: 28765896 PMC: 5646959. DOI: 10.3892/mmr.2017.7096.

References
1.
Palmer H, Gonzalez-Sancho J, Espada J, Berciano M, Puig I, Baulida J . Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001; 154(2):369-87. PMC: 2150773. DOI: 10.1083/jcb.200102028. View

2.
Dalhoff K, Dancey J, Astrup L, Skovsgaard T, Hamberg K, Lofts F . A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer. 2003; 89(2):252-7. PMC: 2394267. DOI: 10.1038/sj.bjc.6601104. View

3.
Baker A, McDonnell D, Hughes M, Crisp T, Mangelsdorf D, Haussler M . Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A. 1988; 85(10):3294-8. PMC: 280195. DOI: 10.1073/pnas.85.10.3294. View

4.
Sarkar F, Li Y, Wang Z, Kong D . Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir. 2009; 64(5):489-500. PMC: 2878773. View

5.
Tokar E, Webber M . Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin Exp Metastasis. 2005; 22(3):275-84. DOI: 10.1007/s10585-005-8393-z. View